KPX Lifescience.Co.Ltd (114450) — Cash Flow Reinvestment Rate
KPX Lifescience.Co.Ltd (114450) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting ₩768.79 Million (capex ₩275.98 Million plus investments ₩492.81 Million) from operating cash flow of ₩3.33 Billion. Check KPX Lifescience.Co.Ltd (114450) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
KPX Lifescience.Co.Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for KPX Lifescience.Co.Ltd across 10 annual periods. Explore investment intensity of KPX Lifescience.Co.Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year capital reinvestment analysis for KPX Lifescience.Co.Ltd. For live market cap and broader valuation context, see 114450 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.12x | ₩3.74 Billion | ₩525.49 Million | ₩462.71 Million | ▼ -67.0% |
| 2023 | 21.60x | ₩7.99 Billion | ₩370.02 Million | ₩475.02 Million | ▲ +106.6% |
| 2021 | 10.45x | ₩6.39 Billion | ₩611.38 Million | ₩3.44 Billion | ▲ +152.0% |
| 2020 | 4.15x | ₩7.89 Billion | ₩1.90 Billion | ₩2.67 Billion | ▲ +74.1% |
| 2019 | 2.38x | ₩10.11 Billion | ₩4.24 Billion | ₩3.60 Billion | ▲ +46.5% |
| 2018 | 1.63x | ₩8.75 Billion | ₩5.38 Billion | ₩7.49 Billion | ▲ +78.2% |
| 2017 | 0.91x | ₩5.19 Billion | ₩5.68 Billion | ₩4.31 Billion | ▲ +39.7% |
| 2016 | 0.65x | ₩4.62 Billion | ₩7.07 Billion | ₩1.60 Billion | ▲ +123.3% |
| 2015 | 0.29x | ₩1.64 Billion | ₩5.62 Billion | ₩526.82 Million | ▼ -27.8% |
| 2014 | 0.41x | ₩1.65 Billion | ₩4.09 Billion | ₩838.78 Million | — |